Liquidia stock slides after Needham swaps LQDA off its 2026 Conviction List
New York, Jan 6, 2026, 15:31 EST — Regular session Shares of Liquidia Corp (LQDA) fell 6.2% to $30.17 in afternoon trading on Tuesday after Needham removed the stock from its 2026 “Conviction List,” a report said. The shares hit a session low of $29.47, down from Monday’s close of $32.15. The decline stood out against a firmer biotech backdrop. The SPDR S&P Biotech ETF was up about 1.1% and the iShares Nasdaq Biotechnology ETF gained about 2.0%. For Liquidia, sentiment often tracks expectations for Yutrepia, its inhaled treprostinil powder used to treat pulmonary arterial hypertension (PAH), a form of
